ArticleNature communications2021

Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia.

Hu Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.